Trends in antidepressant overdoses
暂无分享,去创建一个
[1] A. Simmons,et al. Case of self-poisoning with multiple antidepressant drugs. , 1970, Lancet.
[2] Poisoning by tricyclic drugs. , 1972, British medical journal.
[3] T. Litovitz,et al. 1983 annual report of the American Association of Poison Control Centers National Data Collection System. , 1984, The American journal of emergency medicine.
[4] T. Litovitz,et al. 1985 Annual Report of the American Association of Poison Control Centers National Data Collection System. , 1986, The American journal of emergency medicine.
[5] T. Litovitz,et al. 1986 annual report of the American Association of Poison Control Centers National Data Collection System. , 1987, The American journal of emergency medicine.
[6] T. Litovitz,et al. 1987 annual report of the American Association of Poison Control Centers National Data Collection System. , 1988, The American journal of emergency medicine.
[7] T. Litovitz,et al. 1988 annual report of the American Association of Poison Control Centers National Data Collection System. , 1989, The American journal of emergency medicine.
[8] T. Litovitz,et al. 1989 annual report of the American association of poison control centers national data collection system , 1990 .
[9] S. Kapur,et al. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. , 1991, Archives of general psychiatry.
[10] T. Litovitz,et al. 1990 annual report of the American Association of Poison Control Centers National Data Collection System. , 1991, The American journal of emergency medicine.
[11] M. Stanley,et al. Antidepressants and Suicide Risk: Issues of Chemical and Behavioral Toxicity , 1992, Journal of clinical psychopharmacology.
[12] A. Leon,et al. The effect of access to lethal methods of injury on suicide rates. , 1992, Archives of general psychiatry.
[13] T. Litovitz,et al. 1991 annual report of the American Association of Poison Control Centers National Data Collection System. , 1992, The American journal of emergency medicine.
[14] T. Litovitz,et al. 1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1993, The American journal of emergency medicine.
[15] The toxicity and dose of desipramine hydrochloride. , 1994, JAMA.
[16] T. Litovitz,et al. 1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1999, The American journal of emergency medicine.
[17] D. D'mello,et al. The cost of antidepressant overdose. , 1995, General hospital psychiatry.
[18] H. Jick,et al. Antidepressants and suicide , 1995, BMJ.
[19] J. Henry,et al. Relative mortality from overdose of antidepressants , 1995, BMJ.
[20] T. Litovitz,et al. 1994 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1995, The American journal of emergency medicine.
[21] I. Anderson,et al. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis , 1995, BMJ.
[22] T. Litovitz,et al. 1995 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1996, The American journal of emergency medicine.
[23] S. R. Rose,et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2003, The American journal of emergency medicine.
[24] D A Zarin,et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. , 1998, JAMA.
[25] S. Roose,et al. SSRI safety in overdose. , 1998, The Journal of clinical psychiatry.
[26] D. Sclar,et al. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990-1995. , 1998, Clinical therapeutics.
[27] T. Litovitz,et al. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1998, The American journal of emergency medicine.
[28] N. Freemantle,et al. North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care. North of England Anti-depressant Guideline Development Group. , 1999, Family practice.
[29] A. House,et al. Deliberate self poisoning with antidepressant drugs: a comparison of the relative hospital costs of cases of overdose of tricyclics with those of selective-serotonin re-uptake inhibitors. , 2000, Journal of affective disorders.
[30] M. Whooley,et al. Managing depression in medical outpatients. , 2000, The New England journal of medicine.
[31] J. Rose,et al. A mortality index for postmarketing surveillance of new medications. , 2000, The American journal of emergency medicine.
[32] T. Litovitz,et al. 1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2000, The American journal of emergency medicine.
[33] T. Litovitz,et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2001, The American journal of emergency medicine.
[34] J. Markowitz. Antidepressants and suicide risk , 2001, British Journal of Psychiatry.
[35] A. Woolf,et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2002, The American journal of emergency medicine.
[36] H. Leufkens,et al. Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands , 2002, Pharmacoepidemiology and Drug Safety.
[37] Harold Alan Pincus,et al. National trends in the outpatient treatment of depression. , 2002, JAMA.
[38] Adrienne Z. Ables,et al. Antidepressants: update on new agents and indications. , 2003, American family physician.
[39] C. Foxcroft,et al. Prescribing patterns of tricyclic and selective serotonin reuptake inhibitor antidepressants among a sample of adolescents and young adults , 2003, Pharmacoepidemiology and drug safety.
[40] M. Olfson,et al. Relationship between antidepressant medication treatment and suicide in adolescents. , 2003, Archives of general psychiatry.
[41] M. Hotopf,et al. Economic Evaluation of Antidepressive Agents: A Systematic Critique of Experimental and Observational Studies , 2003, Journal of clinical psychopharmacology.
[42] I. Whyte,et al. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. , 2003, QJM : monthly journal of the Association of Physicians.
[43] S. R. Rose,et al. 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2003, The American journal of emergency medicine.
[44] A. Leon,et al. Paroxetine, other antidepressants, and youth suicide in New York City: 1993 through 1998. , 2004, The Journal of clinical psychiatry.
[45] H. Jick,et al. Antidepressants and the risk of suicidal behaviors. , 2004, JAMA.
[46] Douglas Borys,et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2004, The American journal of emergency medicine.
[47] FDA to review “missing” drug company documents , 2004, BMJ : British Medical Journal.
[48] D. Gunnell,et al. Antidepressants and suicide: what is the balance of benefit and harm , 2004, BMJ : British Medical Journal.
[49] Peter Fonagy,et al. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data , 2004, The Lancet.
[50] M. Oquendo,et al. Antidepressants and suicide risk in the United States, 1985-1999. , 2004, The Journal of clinical psychiatry.
[51] Robert D Gibbons,et al. The relationship between antidepressant medication use and rate of suicide. , 2005, Archives of general psychiatry.
[52] K. Hawton,et al. Deliberate self-harm in children and adolescents: a research update , 2005, Current opinion in psychiatry.
[53] D. Gunnell,et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study , 2005, BMJ : British Medical Journal.
[54] S. Zuvekas. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001. , 2005, Health affairs.
[55] Klaus P. Ebmeier,et al. Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants , 2005 .
[56] D. Gunnell,et al. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review , 2005, BMJ : British Medical Journal.
[57] Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials , 2005, BMJ : British Medical Journal.
[58] D. Mines,et al. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram , 2005, Pharmacoepidemiology and drug safety.
[59] A. Flanagan,et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1994, The American journal of emergency medicine.
[60] J. Geddes,et al. Suicide, depression, and antidepressants , 2005, BMJ : British Medical Journal.
[61] D. Klein,et al. The Flawed Basis for FDA Post-Marketing Safety Decisions: The Example of Anti-Depressants and Children , 2006, Neuropsychopharmacology.
[62] J. Savarino,et al. Suicide risk during antidepressant treatment. , 2006, The American journal of psychiatry.
[63] D. Redelmeier,et al. The risk of suicide with selective serotonin reuptake inhibitors in the elderly. , 2006, The American journal of psychiatry.
[64] J. Racoosin,et al. Suicidality in pediatric patients treated with antidepressant drugs. , 2006, Archives of general psychiatry.
[65] R. Baldessarini,et al. Suicidal risk in antidepressant drug trials. , 2006, Archives of general psychiatry.
[66] J. Racoosin,et al. Suicide Rates in Short-term Randomized Controlled Trials of Newer Antidepressants , 2006, Journal of clinical psychopharmacology.